Real-World Benefits for SGLT-2 Inhibitors
Study Finds Moderate Increase in Physical Activity Reduces Glucose, A1c
Omega-6 Fatty Acid Reduces Risk of Type 2 Diabetes
Are Statins Related to Diabetes Progression?
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy In Youth With Type 1 and 2 Diabetes
Why Data-Driven Diabetes Management Systems are the Future
by Guest Writer David Kliff, Diabetic Investor
Dr. Carla Greenbaum on Predicting and Preventing Type 1